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Overview
• Incorporating nanomaterials into ToxCast projectTM
– EPA nanomaterial research strategy
– ToxCast project
– Comptox toxicity and exposure research on nanomaterials
• Databases and tools developed by CompTox
– ACToR
– ToxMiner
– ExpoCast DB and exposure data curation
– Virtual Tissue Knowledgebase (VT-KB)
1
Office of Research and Development (ORD)
www.epa.gov




• Four main research themes:
– Identifying sources, fate, transport, and 
exposure
– Understanding human health and 
ecological effects to inform risk 
assessments and test methods
– Developing risk assessment 
approaches
– Preventing and mitigating risks
June 2009
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Many nanomaterials to evaluate, 











Life cycle assessment; 
State of Science Review
Case-by-case examples:
Screening level assessment:
ToxCastTM: Bioactivity profiling + 
exposure potential 
(EPA Comptox)
• Toxicity and exposure research 
is challenged to keep up with 
development of novel 
nanomaterials and applications
• Assesment of nanomaterial
(NM) like chemicals is typically 
case-by-case
• Prioritization of research and 
screening level assessment of 
NMs are needed.
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Too Many Chemicals Too Little Data (%)

















Inerts CCL 1 & 2 HPV
MPV
9912
Judson et al., 2009, Environ. Health Perspect. 
…and costs too much.
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ToxCast™ project: Diversity of 
in vitro data from HTS assays
• 500 fast, automated chemical screens (in vitro) generating lots of data
• Phase 1: Screened 300+ well characterized chemicals (primarily pesticides) 


















– HepG2 human hepatoblastoma
– A549 human lung carcinoma
– HEK 293 human embryonic kidney
• Primary cells




– Human proximal tubule kidney cells
– Human small airway epithelial cells
• Biotransformation competent cells
– Primary rat hepatocytes
– Primary human hepatocytes
• Assay formats
– Cytotoxicity
– Reporter gene 
– Gene expression
– Biomarker production













Judson et al., 2010, Environ. Health Perspect.
http://www.epa.gov/ncct/toxcast/
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Steps to include NMs in ToxCast™
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• Classes of NM of interest: Au, Ag, CNT, TiO2, CeO2, ZnO, SiO2
* Initial pilot materials
• Major steps:
– Develop handling protocols
• Compare protocols used in Center for Environmental 
Implications of NanoTechnology (CEINT) at Duke Univ., 
ENPRA, and Japan NIST
– Determine concentration ranges to test
• Select based on potential for real world human exposures
– Characterize NMs
• CEINT at Duke Univ.
– Perform High-throughput screening (HTS)
• Analyze HTS data and apply ToxCast methodology TEM image of TiO2
Office of Research and Development (ORD)
www.epa.gov
Using Multiple-path particle dosimetry
model to determine concentrations
• Open-source computational MPPD modeling 
tool (Applied Research Associates)
– Calculates human respiratory tract particle 
deposition/clearance after inputing NM aerosol 
conc.
• Reviewed literature on NM aerosol concentrations 
in occupational settings
– Typically < 0.1 mg/m3 for TiO2, Ag, CNTs
• Performed sensitivity analysis
– Most important inputs: aerosol concentration, 
breathing conditions (heavy, light exercise, rest), 
aspect ratio (for CNTs)
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Integrated Science Assessment for Particulate 
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Alveolar mass retained for a full working lifetime to 1 
mg/m3  Similar to high-end doses (~ 100-200 ug/mL) 
typical of in vitro testing
• Exposure duration: Full working lifetime 
of 45 years (8 h/day, 5 days/week)
• Exposure duration: 24 hours
• Ag & TiO2 nanoparticles




Selected NM medium/cell combination
As received (dry powder or 
suspension)
 In stock (prepared per OECD 




• Size distribution, shape
(TEM                 DLS            Cytovita )
• Surface area
(BET                  Calculation from DLS          )
• Chemical composition,crystal form 
(XRD                 Possibly ICP-MS)
• Rate of dissolution                            
(ICP-AES               Possibly ion specific probe)
• Surface composition/contamination 
(TOC                       Possibly SEM+EDS)
• Surface charge, zeta potential 
(Zetasizer )
• Possibly hydrophobicity, surface redox react.
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• Colloboration with Center for Environmental Implications of NanoTechnology (CEINT) at 
Duke Univ.








Connections are made 
by looking for statistical 
associations across 
many chemicals
Requires both in vitro 
and in vivo data
Once a model is “qualified”:
• New chemicals (nanomaterials) can be run through assays
• Results of assays can be used to rank chemicals (nanomaterials) 
for potential to cause toxicity
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NCCT databases and tools
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• Aggregated Computational Toxicology Resource  (ACToR)
• Database to find chemical toxicity info from large number of sources.
• ToxMiner
• Database to house detailed data ToxCast and ToxRefDB - used for 
ToxCast analyses.
• ExpoCast DB
• Detailed chemical concentration by media data from observational 
exposure studies.
• Virtual tissue Knowledge base (VT-KB)
• Tool developed to curate literature on chemical toxicity
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ACToR: Aggregated Computational 
Toxicology Resource
Tabular Data,
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ACToR goals and data sources
• Compile all publicly available information on environmental chemicals
• Make data available for downloading, data mining
– Available through data.gov
– Entire DB can be downloaded and installed locally
• Make it easy to see data gaps
– Provides resource for EPA testing programs
• Make it widely used
– over 2000 regular users
• EPA (OPP, OPPT, NCEA, NERL)
• FDA, NIH, CDC, OSHA, USDA




















• Computable representation of structure
• Open source CASRN-like “code” for linking data from 
many sources
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• Allows data analyses
– Statistical associations (R-script)
– Biologically driven data mining
Store in vitro HTS assay data 
on NMs
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Intranet wiki:                                                            



















EPA/NCCT    
servers
EPA               
servers
ToxCast assay data workflow

































































• Data from NERL studies
1) American Health Home 
Survey
2) HUD Child Care Center 
Survey (“CCC” )
3) CTEPP – NC
4) CTEPP – OH
• Full raw data sets available to 
download
• Browse data capability
• By study name, chemical list, 
media list
• Descriptive statistics 
capabilities
Store exposure aerosol concentrations 
of NM in occupational settings

















Pilot curation of 
exposure data into CTD
Office of Research and Development (ORD)
www.epa.gov
Summary
• Results of nanomaterial ToxCast screening and physicochemical 
characterization will be publicly accessible through ACToR
• For chemicals, informatics infrastructure is in place for:
–Capturing chemical identity
–Capturing in vitro and in vivo data
–Measuring and modeling biotransformation / metabolism
–Building statistical and biologically-based models
–Prioritizing chemicals for targeted testing
–Dealing with 104 to 106 chemicals
• Challenges for nanomaterials
–Material identity
–Quantification of imaging characterization results
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